Xiliang Cong
- Topics
- Gastric Cancer Management and Outcomes (8 papers)Inflammatory Biomarkers in Disease Prognosis (7 papers)Metastasis and carcinoma case studies (4 papers)
- Cited by
- OncologyImmunologyCancer Research
- Journals
- BioMed Research InternationalJournal of Experimental & Clinical Cancer ResearchInternational Immunopharmacology
- Partner nations
- China
In The Last Decade
Xiliang Cong
14 papers receiving 473 citations
Peers
Comparison fields: 5 of 65
- Oncology 283
- Immunology 161
- Pulmonary and Respiratory Medicine 150
- Molecular Biology 129
- Cancer Research 112
Countries citing papers authored by Xiliang Cong
This map shows the geographic impact of Xiliang Cong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiliang Cong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiliang Cong more than expected).
Fields of papers citing papers by Xiliang Cong
This network shows the impact of papers produced by Xiliang Cong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiliang Cong. The network helps show where Xiliang Cong may publish in the future.
Co-authorship network of co-authors of Xiliang Cong
This figure shows the co-authorship network connecting the top 25 collaborators of Xiliang Cong. A scholar is included among the top collaborators of Xiliang Cong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiliang Cong. Xiliang Cong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 17 | |
| 2 | 5 | |
| 3 | 33 | |
| 4 | 18 | |
| 5 | 18 | |
| 6 | 220 | |
| 7 | 11 | |
| 8 | 30 | |
| 9 | 32 | |
| 10 | 6 | |
| 11 | 74 | |
| 12 | 6 | |
| 13 | [Impact of preoperative lymphocyte to monocyte ratio on the prognosis of the elderly patients with stage II(-III( gastric cancer]. | 8 |
| 14 | [Application of microsatellite alteration of urine sediment in the early diagnosis of bladder cancer]. | 1 |
About Xiliang Cong
Xiliang Cong is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Internal Medicine, having authored 14 papers that have together received 479 indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (8 papers), Inflammatory Biomarkers in Disease Prognosis (7 papers) and Metastasis and carcinoma case studies (4 papers). The work is most often cited by research in Oncology (283 citations), Immunology (161 citations) and Cancer Research (112 citations). Xiliang Cong has collaborated with scholars based in China. Frequent co-authors include Yingwei Xue, Sen Li, Shubin Song, Zhiguo Li, Chunfeng Li, Yimin Wang, Hongfeng Zhang, Wenpeng Wang, Hongyu Gao and Yuzhou Zhao. Their work appears in journals such as BioMed Research International, Journal of Experimental & Clinical Cancer Research and International Immunopharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.